Repevax

BIOLOGICAL4 trials

Sponsors

Stichting Radboud University Medical Center, Sanofi Pasteur, a Sanofi Company, Pfizer, Public Health England

Conditions

HealthyMeningitisMeningococcal VaccineN Meningitidis Serogroup BPertussis or 'whooping cough'RepevaxResponses to Infant ImmunisationsrLP2086

Phase 2

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

CompletedNCT01323270

PfizerMeningitis, Meningococcal Vaccine, N Meningitidis Serogroup B +2

Start: 2011-03-18End: 2013-02-19Updated: 2022-10-27

Phase 3

Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults

CompletedNCT00928785

Sanofi Pasteur, a Sanofi CompanyHealthy

Start: 2009-07-31End: 2009-12-31Updated: 2017-09-11

Phase 4

A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants

CompletedNCT02145624

Public Health EnglandResponses to Infant Immunisations

Start: 2014-10-31End: 2017-12-31Updated: 2020-10-01

A phase 4, randomised vaccination study in healthy adults to investigate the effects of acellular pertussis vaccine on colonisation with Bordetella pertussis using controlled human infection (KIM-study)

RecruitingCTIS2023-508416-35-00

Stichting Radboud University Medical CenterPertussis or 'whooping cough'

Start: 2024-10-16Target: 99Updated: 2026-01-26

Related Papers

Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older.

2022-02-112 citations

A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants.

2021-06-0815 citations

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data.

2020-07-172 citations

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents

Journal of the Pediatric Infectious Diseases Society2016-01-2342 citations